Trials / Completed
CompletedNCT00312520
Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of Infancy
The Efficacy and Safety of Intravenous Pulse Steroids Compared to Standard Oral Steroids in the Treatment of Problematic Hemangiomas in Infants: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- The Hospital for Sick Children · Academic / Other
- Sex
- All
- Age
- 1 Month – 4 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if pulse steroids are more efficacious and safer than the standard treatment with oral corticosteroids.
Detailed description
Currently there is no prospective study in hemangioma patients answering critical questions such as: which type of steroid should be used,how much should we use and for how long. This study is an investigator blinded study with two arms:one arm is receiving standard treatment with daily oral corticosteroids and the other is receiving intravenous pulse corticosteroids daily for 3 days, monthly for 3 months. The main outcome of the study is assess the efficacy of each treament modality as the percentage improvement in the hemangioma's appearance. The secondary outcomes are the safety profiles of the two drugs and the changes in the angiogenesis markers as a result of treatment intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prednisolone | |
| DRUG | methylprednisolone |
Timeline
- Start date
- 2002-07-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2006-04-10
- Last updated
- 2018-04-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00312520. Inclusion in this directory is not an endorsement.